Pulmonology devices market seen reaching $2.36 billion by 2030

The Business Research Company says the pulmonology devices market is growing on rising respiratory disease rates, more outpatient care and new diagnostic technologies. The market is projected to climb from $1.5 billion in 2025 to $2.36 billion by 2030, with North America holding the largest share in 2025.

Why it matters: - Pulmonology devices sit at the center of respiratory diagnosis, treatment and monitoring. - Rising COPD and other breathing disorders are increasing demand for tools such as bronchoscopy systems, spirometers, pulse oximeters and ventilators. - The market outlook points to sustained growth in both hospital and outpatient pulmonary care.

What happened: - The Business Research Company released a pulmonology devices market report on Aug. 25, 2026. - The report says the market grew from $1.5 billion in 2025 to an expected $1.66 billion in 2026, a 10.4% CAGR. - The report forecasts the market will reach $2.36 billion by 2030, at a 9.3% CAGR. - North America held the largest share of the pulmonology devices market in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - A free sample is available here. - The full report is available here.

The details: - The report ties near-term growth to higher respiratory disease prevalence, more hospital-based pulmonary procedures, wider use of diagnostic bronchoscopy, growth in pulmonology specialty clinics and more advanced airway management equipment. - Longer-term growth is expected to come from an aging population with respiratory disorders, stronger demand for early lung cancer detection, wider use of disposable medical devices, expansion in outpatient pulmonary care and technology improvements in pulmonary diagnostics. - The report highlights growing use of single-use bronchoscopes, minimally invasive diagnostic tools, imaging-guided biopsy devices and portable pulmonary function testing equipment. - Infection control and patient safety are also becoming bigger priorities in device selection and deployment. - Pulmonology devices include tools used to evaluate lung function, monitor respiratory health, deliver therapy and support patients with breathing disorders. - Examples include spirometers, inhalers, pulse oximeters and ventilators. - The report says a December 2023 JAMA Network Open study projected global COPD cases could reach nearly 600 million by 2050, a 23% increase in prevalence.

Between the lines: - The market story is less about one device category and more about a broader shift toward earlier diagnosis, lower-infection-risk procedures and more care outside the hospital. - Disposable and single-use devices appear positioned to gain as infection control becomes more important. - The COPD projection signals how chronic respiratory disease could keep pressure on health systems and device makers for years. - The report's regional breakdown suggests demand is broad-based, but North America remains the largest commercial base.

What's next: - The report expects technology upgrades, portable testing and minimally invasive diagnostics to keep shaping product demand through 2030. - Market growth will likely track aging populations, respiratory disease prevalence and outpatient pulmonary care expansion. - The Business Research Company also says its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards and market hotspot infographics. - More information is available through the company's contact channels and social media links, including LinkedIn, Facebook and X.

The bottom line: - Pulmonology devices are set for steady growth as respiratory disease burdens rise and care shifts toward earlier, safer and more portable diagnostics.